Nektar Therapeutics | Koszty Sprzedaży



Cost Of Sales Zmiana Data
Agios Pharmaceuticals USD 1.08M 175K 2025-03
ALKERMES USD 49.2M 12.92M 2025-03
Amgen USD 2.6B 507M 2025-03
Baxter International USD 1.74B 73M 2024-12
Biogen USD 629.3M 45.8M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Cipla INR 21.89B 750.6M 2025-03
Dr.Reddys Laboratories INR 28.5B 6.03B 2025-03
Eisai JPY 40.6B 5.33B 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Exelixis USD 19.17M 793K 2025-04
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Grifols EUR 1.21B 143.12M 2024-12
Halozyme Therapeutics USD 48.4M 6.35M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.76B 944M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Takeda JPY 382.08B 34.8B 2025-03
Teva Pharmaceutical Industries USD 1.98B 132M 2025-03
Xencor 10.71M 4.56M 2024-09



Nektar Therapeutics Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.